FOXO4
Senolytic peptide that selectively clears senescent cells via FOXO4-p53 disruption.
$323.00 / unit
1
Total:$323.00
GMP Compliant≥99% PurityGlobal Shipping
FOXO4-DRI is a senolytic peptide designed to interfere with the FOXO4-p53 interaction, selectively triggering apoptosis in senescent (aged) cells while leaving healthy cells unaffected.
Key Benefits
- Selectively clears senescent cells
- Restores tissue function in aged subjects
- Reduces systemic inflammation
- Anti-aging and longevity research
Reconstitution Instructions
- Reconstitute with Bacteriostatic Water
- Gently swirl until dissolved
Dosing Guidelines
- Per research protocol
- Subcutaneous injection
Product Note
FOXO4-DRI represents a new class of senolytic peptides.